Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 29,052 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disease;Neurological Clear all

Conditions: Alzheimer's Disease
Interventions: Not listed
Lead sponsor: Orasi Medical, Inc.; Industry
Eligibility: 50 Years to 90 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Chicago, Illinois • Elk Grove Village, Illinois

Conditions: Parkinson's Disease
Interventions: PYM50028, Placebo; Drug
Lead sponsor: Phytopharm; Industry
Eligibility: 35 Years to 75 Years
Enrollment: 425 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 41
States / cities: Scottsdale, Arizona • Irvine, California • La Jolla, California + 37 more

Conditions: Parkinson's Disease
Interventions: Spinning Class, Yoga Class, Dance Class, No Exercise Class; Behavioral · Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Stroke, Acute Ischemic Stroke
Interventions: Repinotan HCl (BAYX3702), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 782 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2004
U.S. locations: 28
States / cities: Los Angeles, California • Oceanside, California • San Diego, California + 25 more

Conditions: Alzheimer Disease, Mild Cognitive Impairment
Interventions: Active Transcranial Direct Current Stimulation (tDCS), Sham Transcranial Direct Current Stimulation (tDCS); Device
Lead sponsor: Minneapolis Veterans Affairs Medical Center; Federal
Eligibility: 60 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Amblyopia
Interventions: OkuStim®, Sham-OkuStim®; Device
Lead sponsor: Wills Eye; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Postoperative Pain After Uterine Fibroid Embolization, Uterine Fibroids (UF), Uterine Fibroids, Pelvic Pain, Pain Management
Interventions: TUNES (Transmucosal Uterosacral Electrical Stimulation), Sham TUNES Device; Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 28 Years to 52 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Dystonia
Interventions: Progressive resistance exercise, Standard of care; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 30 Years to 85 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Chronic Pain, Opioid Use Disorder
Interventions: 400 mg Cannabidiol, 800 mg Cannabidiol, 1200 mg Cannabidiol, Beta carotene oral solution without CBD; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Spinal Cord Injury
Interventions: Autologous bone marrow-derived mesenchymal stem cells.; Biological
Lead sponsor: TCA Cellular Therapy; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Covington, Louisiana

Conditions: Alzheimer Disease
Interventions: Play Serious Games with a Social Robot (Ryan), Play Solitary Games Without a Social Robot; Behavioral
Lead sponsor: DreamFace Technologies, LLC; Industry
Eligibility: 65 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Lakewood, Colorado

Conditions: Mucopolysaccharidosis II
Interventions: Long-term Follow-Up; Other
Lead sponsor: REGENXBIO Inc.; Industry
Eligibility: Male only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 3
States / cities: San Francisco, California • New Brunswich, New Jersey • Philadelphia, Pennsylvania

Conditions: Plaque, Atherosclerotic Disease, Heart Disease, Stroke
Interventions: Not listed
Lead sponsor: BG Medicine, Inc; Industry
Eligibility: 55 Years to 80 Years
Enrollment: 7,687 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 2
States / cities: Oakland Park, Florida • Justice, Illinois

Conditions: Pain, Postoperative, Bunion
Interventions: COV155, placebo; Drug
Lead sponsor: Mallinckrodt; Industry
Eligibility: 18 Years and older
Enrollment: 406 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 5
States / cities: Anaheim, California • Pasadena, California • Pasadena, Maryland + 2 more

Conditions: Mood, Anhedonia, Depression
Interventions: Behavioral Activation plus Savoring, Empathic Listening; Behavioral
Lead sponsor: Southern Methodist University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Pulmonary Edema, Pneumonia, Atelectasis, Pleural Effusion, Acute Rejection of Lung Transplant (Disorder), Airway Obstruction, Rib Fractures, Acute Copd Exacerbation, Asthma COPD, Pulmonary Embolism, Hemothorax, Pneumothorax, Mesothelioma, Diaphragmatic Paralysis
Interventions: Portable Dynamic Digital Radiography (DDR); Diagnostic Test
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: LVAD, Frailty, GI Bleed, Right Heart Failure, Infections, Hypertension, Arrhythmias, Stroke
Interventions: HeartMate 3 (R) left ventricular assist device; Device
Lead sponsor: International Consortium of Circulatory Assist Clinicians; Other
Eligibility: 18 Years to 100 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 7
States / cities: San Francisco, California • Gainesville, Florida • Chicago, Illinois + 4 more

Conditions: Stroke, Acute
Interventions: Oxygen, placebo; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Aurora, Colorado • Colorado Springs, Colorado

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Fasudil (WP-0512); Drug
Lead sponsor: Woolsey Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 9
States / cities: Phoenix, Arizona • Aurora, Colorado • Denver, Colorado + 6 more

Conditions: Depression, Anhedonia
Interventions: Continuous theta burst stimulation (cTBS), Positive Affect Training, Ketamine Injectable Solution; Device · Behavioral · Drug
Lead sponsor: Erika Forbes; Other
Eligibility: 15 Years to 25 Years
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Gastroparesis
Interventions: Gastric Electrical Stimulator, Enterra, Medtronics, Inc.; Device
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Chronic Pancreatitis, Chronic Pain, Acute Recurrent Pancreatitis
Interventions: Quantitative Sensory Test 1, Quantitative Sensory Test 2, Quantitative Sensory Test 3; Diagnostic Test
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 5 Years to 17 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: IUD, Abnormal Uterine Bleeding, Pain, Cervical
Interventions: Carevix, Tenaculum; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Spinal Cord Injuries, Spinal Cord Diseases
Interventions: Remote CMR, Remote Exercise; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 75 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)

Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)

The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease

Repinotan in Patients With Acute Ischemic Stroke

tDCS and Cognitive Training for Mild Cognitive Impairment and Alzheimer's Dementia

Transcorneal Electrical Stimulation (TES) for the Treatment of Amblyopia

Transmucosal Uterosacral Electrical Stimulation for Pelvic Pain Relief

Effects of Exercise on Dystonia Pathophysiology

Cannabidiol in Opioid Use Disorder and Chronic Pain

Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury

Socially Assistive Robots for Interaction With Older Adults With Dementia

Long-term Follow-Up for RGX-121

BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population

Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain

Behavioral Activation Plus Savoring for University Students

Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

The Role of Hyperoxia in Acute Ischemic Stroke

Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)

Anhedonia, Development, and Emotions: Phenotyping and Therapeutics

Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis

Pancreatic Quantitative Sensory Testing (P-QST)

Assessing Pain and Effectiveness of Carevix Device for IUD Insertions

Remotely Delivered Cognitive Multisensory Rehabilitation for Sensory and Motor Recovery After Spinal Cord Injury